members (consisting of executives and representatives from 38 securities firms) held discussions and shared views regarding operations that may affect trust and confidence in the Thai capital market such as

(Normal entry) was Baht 365.04 million which decreased 6.48% comparing to the year 2017 of Baht 390.34 million. Sales and administrative expenses (Special entry) was Baht 86.29 million result from remedy

of both treatment of industrial waste business division and property development business division is 342.4 million Baht compared with same period of year 2016 amounted 378.6 million Baht, decreased

Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,454.77 617.92 Cost of selling medical equipment 125.25 122.84

Ramkhamhaeng Hospital Public Company Limited and its subsidiaries are as follows. Unit : Million baht 2020 2019 Cost of medical treatment 1,373.18 644.93 Cost of selling medical equipment 166.98 94.11

division represented 7.3% and other income represented 38.6%. (See more details from Section (1) and Section (2)) Table 1: Shared comparison of revenues between year 2019 and 2018 Year Treatment of

subsidiaries have the revenues from medical treatment of 947.83 million baht, which is a 7.48 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

subsidiaries have the revenues from medical treatment of 899.25 million baht, which is a 15.55 % increase from the previous year. The revenues can from the two hospitals are broken down as follows

capital market. Representatives from digital asset businesses in the United States also joined the discussion. The SEC representatives shared the SEC’s roles and strategic priorities in driving the Thai

this area, identifying the key practical issues: the rights and equitable treatment of shareholders and other financial stakeholders, the role of non-financial stakeholders, disclosure and transparency